Identifying patient populations vulnerable to viral infection and methods of inducing heterologous immunity in same
US11938181B2 · kind B2 · utility
0Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 9, 2021 |
| Grant date | Mar 26, 2024 |
| Priority date | — |
| Expiry date | Jul 9, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This application relates to methods for assessing patient populations and determining subpopulations vulnerable to viral infection, methods of reducing the risk of infection and/or inducing heterologous immunity to said viral infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.